A validated chemiluminescence immunoassay for methotrexate (MTX) and its application in a pharmacokinetic study. Issue 1 (30th November 2015)
- Record Type:
- Journal Article
- Title:
- A validated chemiluminescence immunoassay for methotrexate (MTX) and its application in a pharmacokinetic study. Issue 1 (30th November 2015)
- Main Title:
- A validated chemiluminescence immunoassay for methotrexate (MTX) and its application in a pharmacokinetic study
- Authors:
- Song, Zhaorui
Wang, Yufen
Dong, Yaqing
Xu, Kun
Long, Hao
Deng, Chuan
Yin, Yongmei
Eremin, Sergei A.
Meng, Meng
Xi, Rimo - Abstract:
- Abstract : Polyclonal antibodies for anticancer drug methotrexate (MTX) were originally produced, and a chemiluminescence immunoassay was developed for plasma MTX determination. Abstract : For routine monitoring of the pharmacokinetic behavior of anticancer drug methotrexate (MTX), polyclonal antibodies for MTX were originally produced, and a sensitive chemiluminescence immunoassay (CLIA) was developed for the determination of plasma MTX. Three kinds of coupling reagents (EDC, CDI and isobutyl chloroformate) were utilized to synthesize MTX immunogens. The coupling ratio, titer and sensitivity of polyclonal antibodies for each immunogen were evaluated. Consequently, MTX–EDC–cBSA was found to be the optimal immunogen since it showed the highest coupling ratio and yielded antibodies with the highest sensitivity. Under optimal conditions, the developed CLIA showed a limit of detection (LOD) of 4.3 ng mL −1 in buffer and 9.1 ng mL −1 in plasma with acceptable coefficients of variations (<14.9%). The method exhibited no cross-reaction with the MTX metabolite (7-OH MTX) and structural analogs. When applied in a pharmacokinetic study, the CLIA results were statistically consistent with the HPLC method in measuring key pharmacokinetic parameters ( t 1/2, C max, AUC0–12 and MRT0–12 ). In conclusion, the CLIA method showed advantages of simple sample preparation, low cost, high sensitivity and good reproducibility. These properties make it a potential tool in the rapid detection of MTXAbstract : Polyclonal antibodies for anticancer drug methotrexate (MTX) were originally produced, and a chemiluminescence immunoassay was developed for plasma MTX determination. Abstract : For routine monitoring of the pharmacokinetic behavior of anticancer drug methotrexate (MTX), polyclonal antibodies for MTX were originally produced, and a sensitive chemiluminescence immunoassay (CLIA) was developed for the determination of plasma MTX. Three kinds of coupling reagents (EDC, CDI and isobutyl chloroformate) were utilized to synthesize MTX immunogens. The coupling ratio, titer and sensitivity of polyclonal antibodies for each immunogen were evaluated. Consequently, MTX–EDC–cBSA was found to be the optimal immunogen since it showed the highest coupling ratio and yielded antibodies with the highest sensitivity. Under optimal conditions, the developed CLIA showed a limit of detection (LOD) of 4.3 ng mL −1 in buffer and 9.1 ng mL −1 in plasma with acceptable coefficients of variations (<14.9%). The method exhibited no cross-reaction with the MTX metabolite (7-OH MTX) and structural analogs. When applied in a pharmacokinetic study, the CLIA results were statistically consistent with the HPLC method in measuring key pharmacokinetic parameters ( t 1/2, C max, AUC0–12 and MRT0–12 ). In conclusion, the CLIA method showed advantages of simple sample preparation, low cost, high sensitivity and good reproducibility. These properties make it a potential tool in the rapid detection of MTX for therapeutic drug monitoring (TDM). … (more)
- Is Part Of:
- Analytical methods. Volume 8:Issue 1(2016)
- Journal:
- Analytical methods
- Issue:
- Volume 8:Issue 1(2016)
- Issue Display:
- Volume 8, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 8
- Issue:
- 1
- Issue Sort Value:
- 2016-0008-0001-0000
- Page Start:
- 162
- Page End:
- 170
- Publication Date:
- 2015-11-30
- Subjects:
- Chemistry, Analytic -- Periodicals
Analytical biochemistry -- Periodicals
Chemical laboratories -- Standards -- Periodicals
543.1905 - Journal URLs:
- http://pubs.rsc.org/en/Journals/JournalIssues/AY ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/c5ay02270c ↗
- Languages:
- English
- ISSNs:
- 1759-9660
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0897.103700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 1578.xml